UNI-EN 56:Current report 56 SPH AGM - 19.06.2015
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| | UNI - EN REPORT No | 56 | / | 2015 | | ||||||
| Date of issue: | 2015-06-15 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Current report 56 SPH AGM - 19.06.2015 | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sopharma AD (the “Company") hereby notifies all shareholders of the Company, that the Annual General Meeting, convened by the Board of Directors for 19 June 2015 at 11:00 will take place at Sopharma Business Towers, Building B, floor 3, 5 Lachezar Stanchev Str.. The registration begins at 9:30. All shareholders of the company are invited to participate at the General Meeting in person or by proxy. As a prerequisite for the technical provisioning of the Annual General Meeting of Shareholders, copies of all letters of attorney and up-to-date accompanying documents must be presented to the Company on paper or electronically by the end of the workday preceding the date of the AGM, namely 5 p.m. on 18 June 2015. On the basis of art. 16, par 3 of the Company's Articles of Association the Board of Directors notifies the shareholders that the General Meeting, scheduled for 19 June 2015 will accept voting by correspondence or electronic means in accordance with the rules included in the invitation for the AGM available on the web site of the company. We would like to thank all shareholders for their understanding and cooperation. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Current report 56 SPH AGM - 19.06.2015.doc Current report 56 SPH AGM - 19.06.2015.doc | Current report 56 SPH AGM - 19.06.2015 | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2015-06-15 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 7.09 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
